Patents Assigned to Memorial Sloan-Kettering Cancer Center Cell Therapeutics, Inc.
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20030099719
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: September 30, 2002
    Publication date: May 29, 2003
    Applicant: Memorial Sloan-Kettering Cancer Center Cell Therapeutics, Inc.
    Inventors: Raymond P. Warrell, Pier P. Pandolfi, Janice L. Gabrilove, Ralph Ellison, Steven Soignet